AMAG Pharma (AMAG) Misses Q2 EPS by 21c
Tweet
Share
E-mailGet Alerts AMAG Hot Sheet
Price: $13.75 --0%
Financial Fact:
License fee and other collaboration revenues: 40K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
License fee and other collaboration revenues: 40K
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
AMAG Pharma (NASDAQ: AMAG) reported Q2 EPS of ($0.58), $0.21 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $146.25 million versus the consensus estimate of $155.81 million.
For earnings history and earnings-related data on AMAG Pharma (AMAG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
- Reading (RDI) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
